Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I totally agree with your figures. And I think that most probably Mr. Koss already has the buyer(s) waiting impatiently for the results...
I would hate to be in the shoes of the traders who have no shares or are selling to make a pittance.... because there could also be a trading halt !
BUYOUT = %100 FOR SURE !!!
You are absolutely right !!!
Regen Biopharma's patents are worth 100K more than the bills !!!
Mr. Koos is keeping his word when he told me :
......that after the media hype we need to give value to the company and that Regen BioPharma will be in the top ten biotech companies.....
The support (buying zone) is at about .007 and it has already been touched
Wrong !
Mass emotions are identical and therefore quantifiable....
After the third wave of bullish impulse and a bar of exhaustion (large candlestick) with large volumes, a technical retracement is inevitable....
Don't worry !
If we refer to the mathematical technique of the swing I would say rather 0.16 / 0.20
As the saying goes :
" I like people who dream the impossible ".
Very Very Good Sign !!!!!!!
I meant mountains of Gold or Rhodium or better Californium (27 million dollars per gram)
RGBP BUYOUT= %100 4 SURE !!!
Regen Biopharma has 21 patents that are worth their weight in gold !
Do you really think that Mr. Koos is going to say on a PR " go ahead without risk traders because I sold the company and I leave you time to buy the shares ! "....
I think that those who are not in it risk a lot !!!
Because there is a strong probability that one day there will be a suspension of quotation..... because of a buyout.... which was stipulated indirectly (to protect itself) on an 8K.....
Well Done Sid !!!
Very soon 0.001
Me too !
Break of the .0.001 threshold today (?)
I think you are absolutely right and this is going to be the most likely scenario...
The shares of nanocap biotech Regen BioPharma (OTCPK:RGBP) surged 21% on Wednesday to reach the highest level since May after the company announced the submission of a U.S. patent application related to a mRNA cancer immunotherapeutic vaccine.
The provisional patent application covers the use of dendritic cell technologies to enhance the company’s patented survivin mRNA cancer immunotherapeutic vaccine, Regen (OTCPK:RGBP) said.
"The currently filed application discloses means of significantly increasing efficacy by combining modified-mRNA with unique cellular immunotherapy as well as adjuvant approaches,” Chief Executive Dr. David Koos remarked.
In 2021, the U.S. Patent and Trademark Office awarded the patent # 11,090,332 for Regen (OTCPK:RGBP), covering the IP rights related to the composition of matter of survivin modified-mRNA useful for training the immune system to destroy cancer.
Read more about Regen’s (OTCPK:RGBP) intellectual property portfolio.
New CEO (?)
In Koos We Trust !!!
For most of us, except for sid, this may seem like a lot of money, but this has to be put into perspective compared to the market capitalization of a Big Pharma at about 5%(M.Cap : LLY 315B, PFE 293B) for the buyout of RegenBiopharma......that is to say a trifle.....a straw....
From Dr Koos...
Ha ! Yes ! Im also ok with this !!!
Mr. Koos wants a minimum of $2.00
No, that's not how the calculation works...
Yeeeess !!!
We answer on a link of Twitter why censorship.....?!
Mamma mia !!!
Acute Respiratory Distress Syndrome Pipeline :
Emerging Therapies and Key pharma players involved by DelveInsight | Pfizer, Regeneron Pharmaceuticals, Regen BioPharma, Omidubicel and Others
https://www.marketwatch.com/press-release/acute-respiratory-distress-syndrome-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-pfizer-regeneron-pharmaceuticals-regen-biopharma-omidubicel-and-others-2022-07-13
Would there be so much bs on a stock that is worthless ?..... I don't think so !!!
Your post proves that you are bitching....lol !!!!
BUYOUT : %100 FOR SURE...
FOMO time...
NDA...
FOMO $$$
Thomas Itchim still works for Regen Biopharma, we can see that on his Twitter account where he quotes RGBP....
No need to work for the company, just give the company the rights to exploit the patents. But on Twitter Dr. T.Ichim confirmed that he was following the development of Regen Biopharma and its patents.....